Sradha Kotwal's Publications

About Sradha Kotwal's Publications

Program Head, Renal and Metabolic Division

  • Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

    The Lancet Date published:

  • A Process Evaluation of the National Implementation of a Bundle for Central Venous Catheter Care for Hemodialysis

    Kidney360 Date published:

  • HAEMODIALYSIS CATHETER UTILISATION IN NEW ZEALAND: REPORT FROM THE REDUCCTION TRIAL

    Date published:

  • SHOULD FAILING HAEMODIALYSIS CATHETERS BE REWIRED OR REMOVED AND REPLACED: INSIGHTS FROM THE NATIONAL REDUCCTION TRIAL

    Date published:

  • BURDEN OF HAEMODIALYSIS CATHETER-RELATED BLOODSTREAM INFECTIONS IN AUSTRALIA: A NATIONAL DATA-LINKAGE STUDY

    Date published:

  • ASSIST STUDY DESIGN: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATHY (IGAN) ON SGLT2I

    Date published:

  • PRACTICE PATTERNS IN A SPECIALIST HYPERTENSION CLINIC

    Date published:

  • RISK FACTORS ASSOCIATED WITH 30-DAY MORTALITY FOLLOWING COVID-19 INFECTION IN AUSTRALIAN AND NEW ZEALAND PATIENTS ON KIDNEY REPLACEMENT THERAPY

    Date published:

  • CONSTRICTIVE URAEMIC PERICARDITIS IN ACUTE KIDNEY INJURY

    Date published:

  • Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial

    BMJ Date published:

  • Medication use and hospital-acquired acute kidney injury: an electronic health record-based study

    Internal Medicine Journal Date published:

  • Should Corticosteroids Be Used to Treat Biopsy-Proven Drug-Induced Acute Interstitial Nephritis?: CON

    Kidney360 Date published:

  • Impact of SGLT2 inhibitors on the kidney in people with type 2 diabetes and severely increased albuminuria

    Expert Review of Clinical Pharmacology Date published:

  • Platform Clinical Trials Within Nephrology-Interpreting the Evidence

    American Journal of Kidney Diseases Date published:

  • Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial

    Trials Date published:

  • Electronic alerts and a care bundle for acute kidney injury-an Australian cohort study

    Nephrology Dialysis Transplantation Date published: